NCT01542307View on ClinicalTrials.gov

Normobaric Oxygen (NBO) Therapy in Acute Migraine

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Migraine
Interventions
BIOLOGICAL

Oxygen

Oxygen is inhaled for 30 minutes during migraine attack

BIOLOGICAL

Room air

Placebo

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT01542307 - Normobaric Oxygen (NBO) Therapy in Acute Migraine | Biotech Hunter | Biotech Hunter